Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 16 | 2024 | 251 | 4.670 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 5 | 2022 | 23 | 3.480 |
Why?
|
Atrial Fibrillation | 17 | 2022 | 345 | 3.150 |
Why?
|
Electrocardiography | 19 | 2024 | 495 | 2.430 |
Why?
|
Heart Rate | 10 | 2024 | 492 | 1.810 |
Why?
|
Heart Atria | 7 | 2022 | 281 | 1.670 |
Why?
|
Heart Conduction System | 5 | 2023 | 112 | 1.620 |
Why?
|
Computer Simulation | 11 | 2011 | 1095 | 1.310 |
Why?
|
Brugada Syndrome | 8 | 2017 | 14 | 1.190 |
Why?
|
Tachycardia | 2 | 2023 | 37 | 1.130 |
Why?
|
Respiration | 7 | 2014 | 266 | 1.100 |
Why?
|
Respiratory Center | 5 | 2014 | 53 | 1.030 |
Why?
|
Cardiac Pacing, Artificial | 6 | 2024 | 96 | 1.010 |
Why?
|
Pulmonary Veins | 5 | 2019 | 88 | 0.950 |
Why?
|
Heart Block | 2 | 2020 | 31 | 0.930 |
Why?
|
Tertiary Lymphoid Structures | 1 | 2023 | 2 | 0.930 |
Why?
|
Models, Biological | 12 | 2011 | 1764 | 0.920 |
Why?
|
Boron Neutron Capture Therapy | 8 | 2011 | 11 | 0.860 |
Why?
|
Action Potentials | 8 | 2024 | 590 | 0.860 |
Why?
|
Ventricular Fibrillation | 8 | 2017 | 66 | 0.840 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2011 | 408 | 0.760 |
Why?
|
Neurons | 11 | 2014 | 1565 | 0.720 |
Why?
|
Neurotransmitter Agents | 3 | 2010 | 107 | 0.710 |
Why?
|
Thromboembolism | 2 | 2017 | 119 | 0.660 |
Why?
|
Electrophysiologic Techniques, Cardiac | 5 | 2024 | 50 | 0.660 |
Why?
|
Respiratory Mechanics | 4 | 2014 | 102 | 0.660 |
Why?
|
Accessory Atrioventricular Bundle | 1 | 2018 | 1 | 0.650 |
Why?
|
Pre-Excitation Syndromes | 1 | 2018 | 3 | 0.650 |
Why?
|
Heart Ventricles | 4 | 2018 | 778 | 0.620 |
Why?
|
Ventricular Function, Left | 3 | 2019 | 602 | 0.610 |
Why?
|
Vibration | 1 | 2017 | 48 | 0.600 |
Why?
|
Synaptic Transmission | 7 | 2019 | 225 | 0.590 |
Why?
|
Knee Joint | 1 | 2017 | 166 | 0.560 |
Why?
|
Humans | 72 | 2024 | 88286 | 0.560 |
Why?
|
Locomotion | 1 | 2017 | 134 | 0.550 |
Why?
|
Transcription, Genetic | 5 | 2017 | 1154 | 0.550 |
Why?
|
Cerebrovascular Disorders | 1 | 2017 | 143 | 0.550 |
Why?
|
Cardiomyopathies | 1 | 2018 | 260 | 0.510 |
Why?
|
Syncope | 4 | 2016 | 34 | 0.510 |
Why?
|
Brain Neoplasms | 7 | 2011 | 773 | 0.510 |
Why?
|
Norepinephrine | 2 | 2014 | 167 | 0.510 |
Why?
|
Male | 58 | 2024 | 41840 | 0.480 |
Why?
|
Anticoagulants | 1 | 2017 | 423 | 0.460 |
Why?
|
Glutamic Acid | 2 | 2019 | 154 | 0.450 |
Why?
|
Female | 49 | 2024 | 45560 | 0.440 |
Why?
|
Bundle of His | 2 | 2024 | 45 | 0.440 |
Why?
|
Periodicity | 3 | 2013 | 119 | 0.440 |
Why?
|
Tachycardia, Ventricular | 4 | 2024 | 120 | 0.440 |
Why?
|
Hypoxia | 4 | 2014 | 650 | 0.430 |
Why?
|
Middle Aged | 37 | 2024 | 25571 | 0.430 |
Why?
|
Borohydrides | 4 | 2011 | 7 | 0.430 |
Why?
|
Nerve Net | 2 | 2014 | 367 | 0.430 |
Why?
|
Time Factors | 15 | 2024 | 5299 | 0.410 |
Why?
|
Glioma | 4 | 2011 | 290 | 0.410 |
Why?
|
Sulfhydryl Compounds | 4 | 2011 | 71 | 0.410 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 2402 | 0.400 |
Why?
|
Electrocardiography, Ambulatory | 4 | 2017 | 27 | 0.400 |
Why?
|
Somatosensory Cortex | 3 | 2007 | 131 | 0.390 |
Why?
|
Biological Clocks | 2 | 2011 | 74 | 0.380 |
Why?
|
Lidocaine | 4 | 2017 | 64 | 0.370 |
Why?
|
Patch-Clamp Techniques | 9 | 2019 | 396 | 0.360 |
Why?
|
Drug Delivery Systems | 2 | 2011 | 179 | 0.360 |
Why?
|
Animals | 34 | 2022 | 27127 | 0.360 |
Why?
|
Defibrillators, Implantable | 3 | 2016 | 140 | 0.350 |
Why?
|
Signal Transduction | 11 | 2016 | 3358 | 0.340 |
Why?
|
Kidney Transplantation | 5 | 2018 | 849 | 0.340 |
Why?
|
Gene Expression Profiling | 7 | 2023 | 1423 | 0.340 |
Why?
|
Aged | 27 | 2019 | 18834 | 0.330 |
Why?
|
ROC Curve | 5 | 2018 | 773 | 0.330 |
Why?
|
Cryosurgery | 2 | 2019 | 52 | 0.330 |
Why?
|
Software | 5 | 2011 | 661 | 0.330 |
Why?
|
Ventricular Function, Right | 1 | 2009 | 145 | 0.320 |
Why?
|
Recurrence | 6 | 2019 | 1170 | 0.320 |
Why?
|
Anti-Arrhythmia Agents | 5 | 2017 | 63 | 0.320 |
Why?
|
Risk Assessment | 10 | 2019 | 2281 | 0.320 |
Why?
|
Risk Factors | 11 | 2019 | 5430 | 0.310 |
Why?
|
Glycolysis | 3 | 2022 | 133 | 0.310 |
Why?
|
Echocardiography, Transesophageal | 3 | 2015 | 346 | 0.300 |
Why?
|
Mice | 14 | 2022 | 11682 | 0.290 |
Why?
|
Granzymes | 2 | 2023 | 94 | 0.280 |
Why?
|
Lac Operon | 2 | 2004 | 47 | 0.280 |
Why?
|
Brain Stem | 4 | 2014 | 167 | 0.280 |
Why?
|
ADP-Ribosylation Factors | 1 | 2006 | 9 | 0.270 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2006 | 43 | 0.270 |
Why?
|
Japan | 9 | 2019 | 303 | 0.270 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 1703 | 0.260 |
Why?
|
Atrioventricular Node | 1 | 2005 | 35 | 0.260 |
Why?
|
Adult | 21 | 2020 | 26230 | 0.260 |
Why?
|
Exercise Test | 3 | 2019 | 164 | 0.250 |
Why?
|
Neck Injuries | 1 | 2004 | 12 | 0.250 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2004 | 20 | 0.250 |
Why?
|
User-Computer Interface | 2 | 2003 | 187 | 0.250 |
Why?
|
Head Protective Devices | 1 | 2004 | 20 | 0.250 |
Why?
|
Cell Membrane | 1 | 2007 | 667 | 0.240 |
Why?
|
Membrane Potentials | 6 | 2019 | 436 | 0.240 |
Why?
|
Accidents, Traffic | 1 | 2004 | 94 | 0.230 |
Why?
|
Immune System Diseases | 1 | 2023 | 26 | 0.230 |
Why?
|
In Vitro Techniques | 7 | 2019 | 995 | 0.220 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2016 | 222 | 0.220 |
Why?
|
Syncope, Vasovagal | 1 | 2002 | 3 | 0.220 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 135 | 0.210 |
Why?
|
Rats | 13 | 2019 | 4028 | 0.210 |
Why?
|
Basal Nucleus of Meynert | 1 | 2002 | 2 | 0.210 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2002 | 22 | 0.210 |
Why?
|
Posture | 1 | 2002 | 124 | 0.210 |
Why?
|
Sodium Channel Blockers | 3 | 2014 | 27 | 0.210 |
Why?
|
Echocardiography | 4 | 2018 | 933 | 0.210 |
Why?
|
Atrial Function, Left | 3 | 2019 | 50 | 0.210 |
Why?
|
Presynaptic Terminals | 1 | 2002 | 41 | 0.200 |
Why?
|
Oxidative Phosphorylation | 1 | 2022 | 52 | 0.200 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2002 | 85 | 0.200 |
Why?
|
Hemodynamics | 1 | 2005 | 726 | 0.200 |
Why?
|
RNA-Binding Protein FUS | 1 | 2021 | 11 | 0.200 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2003 | 210 | 0.190 |
Why?
|
Hepatocytes | 1 | 2022 | 127 | 0.190 |
Why?
|
Antigens, Viral, Tumor | 1 | 2020 | 15 | 0.190 |
Why?
|
Capsid Proteins | 1 | 2020 | 32 | 0.190 |
Why?
|
Arrhythmias, Cardiac | 2 | 2020 | 195 | 0.190 |
Why?
|
BK Virus | 1 | 2020 | 23 | 0.190 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 19 | 0.190 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 28 | 0.190 |
Why?
|
Fibromyalgia | 1 | 2020 | 14 | 0.190 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 300 | 0.190 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 305 | 0.180 |
Why?
|
Escherichia coli | 1 | 2003 | 604 | 0.170 |
Why?
|
Incidence | 4 | 2019 | 1587 | 0.170 |
Why?
|
Exercise Tolerance | 1 | 2019 | 51 | 0.170 |
Why?
|
Chromaffin Cells | 1 | 2019 | 37 | 0.170 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 112 | 0.170 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 1972 | 0.170 |
Why?
|
Exocytosis | 1 | 2019 | 108 | 0.170 |
Why?
|
Multivariate Analysis | 3 | 2017 | 995 | 0.170 |
Why?
|
Spinal Cord Dorsal Horn | 1 | 2019 | 1 | 0.170 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 187 | 0.170 |
Why?
|
Troponin T | 1 | 2019 | 39 | 0.170 |
Why?
|
Substantia Gelatinosa | 3 | 2019 | 4 | 0.170 |
Why?
|
Calcium Signaling | 1 | 2019 | 138 | 0.170 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2018 | 5 | 0.160 |
Why?
|
Polycythemia | 1 | 2018 | 7 | 0.160 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2018 | 14 | 0.160 |
Why?
|
Spinal Cord | 3 | 2005 | 250 | 0.160 |
Why?
|
Boron Compounds | 3 | 2009 | 20 | 0.160 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2018 | 16 | 0.160 |
Why?
|
Spinal Cord Diseases | 1 | 2018 | 28 | 0.160 |
Why?
|
Thrombotic Microangiopathies | 1 | 2018 | 20 | 0.160 |
Why?
|
Logistic Models | 3 | 2017 | 1202 | 0.160 |
Why?
|
Excitatory Postsynaptic Potentials | 4 | 2019 | 87 | 0.150 |
Why?
|
Kidney Diseases | 1 | 2020 | 318 | 0.150 |
Why?
|
Circadian Rhythm | 3 | 2018 | 301 | 0.150 |
Why?
|
Treatment Outcome | 9 | 2024 | 8125 | 0.150 |
Why?
|
Hypokalemia | 2 | 2016 | 23 | 0.150 |
Why?
|
Ankle Joint | 1 | 2017 | 46 | 0.150 |
Why?
|
Rivaroxaban | 1 | 2017 | 12 | 0.150 |
Why?
|
Flufenamic Acid | 2 | 2014 | 13 | 0.150 |
Why?
|
Riluzole | 2 | 2014 | 15 | 0.150 |
Why?
|
Heart Failure | 2 | 2017 | 1169 | 0.150 |
Why?
|
Hindlimb | 1 | 2017 | 92 | 0.150 |
Why?
|
Dabigatran | 1 | 2017 | 25 | 0.150 |
Why?
|
Tachycardia, Supraventricular | 1 | 2017 | 16 | 0.150 |
Why?
|
Anesthetics | 2 | 2007 | 53 | 0.150 |
Why?
|
Lighting | 1 | 2017 | 32 | 0.150 |
Why?
|
Range of Motion, Articular | 1 | 2017 | 151 | 0.150 |
Why?
|
Neural Pathways | 2 | 2010 | 314 | 0.140 |
Why?
|
Pyridones | 1 | 2017 | 53 | 0.140 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2017 | 697 | 0.140 |
Why?
|
Walking | 1 | 2017 | 89 | 0.140 |
Why?
|
Photons | 1 | 2017 | 47 | 0.140 |
Why?
|
Organ Culture Techniques | 2 | 2014 | 135 | 0.140 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 4 | 0.140 |
Why?
|
Glioblastoma | 2 | 2009 | 261 | 0.140 |
Why?
|
Antidiuretic Hormone Receptor Antagonists | 1 | 2016 | 27 | 0.140 |
Why?
|
Chronic Pain | 1 | 2019 | 159 | 0.140 |
Why?
|
Forecasting | 1 | 2017 | 305 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 583 | 0.140 |
Why?
|
Heparin | 1 | 2017 | 184 | 0.140 |
Why?
|
Pyrazoles | 1 | 2017 | 149 | 0.140 |
Why?
|
Neural Inhibition | 2 | 2010 | 97 | 0.140 |
Why?
|
MicroRNAs | 1 | 2021 | 551 | 0.140 |
Why?
|
Benzazepines | 1 | 2016 | 64 | 0.130 |
Why?
|
Biomechanical Phenomena | 1 | 2017 | 465 | 0.130 |
Why?
|
Stroke Volume | 1 | 2018 | 460 | 0.130 |
Why?
|
Electrophysiology | 2 | 2009 | 402 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 3426 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2016 | 162 | 0.130 |
Why?
|
Myocardial Infarction | 3 | 2009 | 372 | 0.130 |
Why?
|
Intraoperative Complications | 1 | 2017 | 188 | 0.130 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 427 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 360 | 0.130 |
Why?
|
Liver | 2 | 2022 | 1238 | 0.130 |
Why?
|
Aged, 80 and over | 5 | 2019 | 6687 | 0.130 |
Why?
|
Brain Infarction | 1 | 2015 | 22 | 0.130 |
Why?
|
Seasons | 1 | 2016 | 233 | 0.130 |
Why?
|
Prognosis | 8 | 2017 | 3740 | 0.130 |
Why?
|
Dinoprostone | 1 | 2014 | 70 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 1 | 2017 | 297 | 0.120 |
Why?
|
Sensitivity and Specificity | 7 | 2016 | 2019 | 0.120 |
Why?
|
Plaque, Atherosclerotic | 1 | 2015 | 56 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 4 | 2019 | 1230 | 0.120 |
Why?
|
Blood Pressure | 1 | 2018 | 885 | 0.120 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 166 | 0.120 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 1587 | 0.120 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 398 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2014 | 99 | 0.110 |
Why?
|
Metabolism | 2 | 2004 | 24 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 2629 | 0.110 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2013 | 73 | 0.110 |
Why?
|
Survival Rate | 3 | 2013 | 1881 | 0.110 |
Why?
|
Calcium Channels, N-Type | 1 | 2013 | 17 | 0.110 |
Why?
|
Intracranial Embolism | 1 | 2013 | 29 | 0.110 |
Why?
|
Cell Cycle | 1 | 2015 | 508 | 0.110 |
Why?
|
Multienzyme Complexes | 2 | 2003 | 65 | 0.110 |
Why?
|
Arousal | 1 | 2013 | 170 | 0.110 |
Why?
|
Young Adult | 4 | 2019 | 6171 | 0.110 |
Why?
|
Elasticity Imaging Techniques | 1 | 2013 | 60 | 0.110 |
Why?
|
Atrial Flutter | 1 | 2012 | 35 | 0.110 |
Why?
|
Sick Sinus Syndrome | 1 | 2012 | 9 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 703 | 0.110 |
Why?
|
Animals, Newborn | 2 | 2013 | 520 | 0.110 |
Why?
|
Follow-Up Studies | 6 | 2017 | 3655 | 0.110 |
Why?
|
PPAR alpha | 2 | 2009 | 10 | 0.110 |
Why?
|
Rats, Wistar | 5 | 2007 | 302 | 0.110 |
Why?
|
Genomics | 3 | 2011 | 740 | 0.110 |
Why?
|
Fenofibrate | 2 | 2009 | 20 | 0.100 |
Why?
|
Transferrin | 2 | 2011 | 19 | 0.100 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2012 | 23 | 0.100 |
Why?
|
Amiodarone | 1 | 2011 | 13 | 0.100 |
Why?
|
Liposomes | 2 | 2011 | 92 | 0.100 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2012 | 103 | 0.100 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2011 | 9 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 884 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2013 | 359 | 0.100 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2013 | 192 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2019 | 8836 | 0.100 |
Why?
|
Atherosclerosis | 1 | 2014 | 254 | 0.100 |
Why?
|
Analysis of Variance | 1 | 2013 | 901 | 0.100 |
Why?
|
Kidney | 1 | 2016 | 1145 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2013 | 321 | 0.090 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2010 | 7 | 0.090 |
Why?
|
Serotonin 5-HT2 Receptor Antagonists | 1 | 2010 | 7 | 0.090 |
Why?
|
Ketanserin | 1 | 2010 | 10 | 0.090 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 857 | 0.090 |
Why?
|
Isoindoles | 1 | 2010 | 14 | 0.090 |
Why?
|
Locus Coeruleus | 1 | 2010 | 4 | 0.090 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2010 | 14 | 0.090 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2010 | 8 | 0.090 |
Why?
|
Receptors, Serotonin, 5-HT2 | 1 | 2010 | 15 | 0.090 |
Why?
|
Hypoglossal Nerve | 1 | 2010 | 26 | 0.090 |
Why?
|
Microinjections | 1 | 2010 | 70 | 0.090 |
Why?
|
Serotonin Antagonists | 1 | 2010 | 35 | 0.090 |
Why?
|
Neurokinin-1 Receptor Antagonists | 1 | 2010 | 35 | 0.090 |
Why?
|
Cancer Vaccines | 1 | 2011 | 159 | 0.090 |
Why?
|
Raphe Nuclei | 1 | 2010 | 37 | 0.090 |
Why?
|
Phenylalanine | 2 | 2009 | 37 | 0.090 |
Why?
|
Coronary Sinus | 1 | 2009 | 8 | 0.090 |
Why?
|
Preoperative Care | 1 | 2012 | 399 | 0.090 |
Why?
|
Mitral Valve | 1 | 2012 | 258 | 0.090 |
Why?
|
Electromyography | 1 | 2010 | 192 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2009 | 48 | 0.090 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 1238 | 0.090 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2009 | 96 | 0.090 |
Why?
|
Prospective Studies | 5 | 2019 | 4257 | 0.090 |
Why?
|
Cells, Cultured | 4 | 2022 | 2873 | 0.090 |
Why?
|
Electric Stimulation | 1 | 2010 | 350 | 0.080 |
Why?
|
Synapses | 2 | 2013 | 267 | 0.080 |
Why?
|
Autocrine Communication | 1 | 2009 | 20 | 0.080 |
Why?
|
Piperidines | 1 | 2010 | 163 | 0.080 |
Why?
|
Software Design | 2 | 2005 | 17 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 94 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2017 | 2742 | 0.080 |
Why?
|
Cell Differentiation | 1 | 2015 | 1511 | 0.080 |
Why?
|
Spectrophotometry, Atomic | 1 | 2008 | 12 | 0.080 |
Why?
|
Sodium | 2 | 2016 | 331 | 0.080 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2009 | 71 | 0.080 |
Why?
|
Observer Variation | 1 | 2009 | 607 | 0.080 |
Why?
|
Drosophila melanogaster | 2 | 2011 | 603 | 0.080 |
Why?
|
Pentobarbital | 1 | 2007 | 20 | 0.080 |
Why?
|
GABA Agonists | 1 | 2007 | 20 | 0.080 |
Why?
|
Receptors, GABA-A | 1 | 2007 | 33 | 0.080 |
Why?
|
Creatinine | 2 | 2020 | 295 | 0.080 |
Why?
|
Transcription Factors | 1 | 2016 | 1639 | 0.080 |
Why?
|
Bayes Theorem | 3 | 2021 | 366 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2019 | 1984 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2008 | 292 | 0.080 |
Why?
|
Disease Models, Animal | 3 | 2020 | 2331 | 0.070 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2007 | 79 | 0.070 |
Why?
|
Receptors, AMPA | 1 | 2007 | 66 | 0.070 |
Why?
|
Diabetic Nephropathies | 1 | 2008 | 87 | 0.070 |
Why?
|
Boron | 1 | 2007 | 3 | 0.070 |
Why?
|
Isoflurane | 1 | 2007 | 64 | 0.070 |
Why?
|
Calcium Channels, Q-Type | 2 | 2019 | 8 | 0.070 |
Why?
|
Calcium Channels, P-Type | 2 | 2019 | 10 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 861 | 0.070 |
Why?
|
Cranial Irradiation | 1 | 2006 | 40 | 0.070 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2006 | 27 | 0.070 |
Why?
|
Antimetabolites | 1 | 2006 | 24 | 0.070 |
Why?
|
Ribonucleosides | 1 | 2006 | 25 | 0.070 |
Why?
|
Analgesics | 1 | 2007 | 119 | 0.070 |
Why?
|
Mice, Inbred ICR | 2 | 2017 | 73 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2007 | 130 | 0.070 |
Why?
|
Meningeal Neoplasms | 1 | 2006 | 63 | 0.070 |
Why?
|
Meningioma | 1 | 2006 | 61 | 0.070 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 7 | 0.070 |
Why?
|
Gliosarcoma | 1 | 2006 | 7 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 3191 | 0.070 |
Why?
|
Information Science | 1 | 2005 | 2 | 0.070 |
Why?
|
Calcium | 2 | 2019 | 1170 | 0.070 |
Why?
|
bcl-2-Associated X Protein | 1 | 2006 | 48 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2009 | 453 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 32 | 0.070 |
Why?
|
Mice, Nude | 1 | 2008 | 813 | 0.070 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2006 | 66 | 0.070 |
Why?
|
Polyethylene Glycols | 1 | 2008 | 365 | 0.070 |
Why?
|
Documentation | 2 | 2003 | 103 | 0.060 |
Why?
|
Pain, Intractable | 1 | 2005 | 10 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2006 | 272 | 0.060 |
Why?
|
Computational Biology | 2 | 2006 | 536 | 0.060 |
Why?
|
Iodobenzenes | 1 | 2004 | 1 | 0.060 |
Why?
|
Thallium | 1 | 2004 | 8 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2012 | 2272 | 0.060 |
Why?
|
Angina Pectoris | 1 | 2004 | 28 | 0.060 |
Why?
|
Immunosuppressive Agents | 2 | 2008 | 993 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2006 | 208 | 0.060 |
Why?
|
Amphiregulin | 1 | 2023 | 7 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2004 | 12 | 0.060 |
Why?
|
Stroke | 1 | 2013 | 973 | 0.060 |
Why?
|
Guanosine Diphosphate | 1 | 2003 | 19 | 0.060 |
Why?
|
Galactose | 1 | 2004 | 32 | 0.060 |
Why?
|
Exons | 1 | 2006 | 452 | 0.060 |
Why?
|
Occipital Bone | 1 | 2004 | 18 | 0.060 |
Why?
|
Adenosine Diphosphate | 1 | 2004 | 55 | 0.060 |
Why?
|
NAD | 1 | 2004 | 65 | 0.060 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2003 | 33 | 0.060 |
Why?
|
Skull Neoplasms | 1 | 2004 | 30 | 0.060 |
Why?
|
Lactose | 1 | 2004 | 27 | 0.060 |
Why?
|
Sarcoma | 1 | 2006 | 220 | 0.060 |
Why?
|
Fatty Acids | 1 | 2004 | 131 | 0.060 |
Why?
|
Hydrolysis | 1 | 2004 | 142 | 0.060 |
Why?
|
Dura Mater | 1 | 2004 | 44 | 0.060 |
Why?
|
Biology | 1 | 2004 | 51 | 0.060 |
Why?
|
Thymus Neoplasms | 1 | 2004 | 43 | 0.060 |
Why?
|
HIV Seronegativity | 1 | 2003 | 13 | 0.060 |
Why?
|
Pleural Effusion, Malignant | 1 | 2003 | 16 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2006 | 1349 | 0.060 |
Why?
|
Models, Genetic | 2 | 2006 | 941 | 0.060 |
Why?
|
Phosphorylation | 1 | 2006 | 1126 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 299 | 0.050 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2023 | 114 | 0.050 |
Why?
|
Electroencephalography | 1 | 2007 | 740 | 0.050 |
Why?
|
Stents | 1 | 2006 | 390 | 0.050 |
Why?
|
Cell Physiological Phenomena | 1 | 2003 | 24 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2004 | 314 | 0.050 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 317 | 0.050 |
Why?
|
Long QT Syndrome | 1 | 2002 | 36 | 0.050 |
Why?
|
Aconitine | 1 | 2002 | 4 | 0.050 |
Why?
|
Ganglia, Sensory | 1 | 2002 | 5 | 0.050 |
Why?
|
Ventromedial Hypothalamic Nucleus | 1 | 2002 | 5 | 0.050 |
Why?
|
Ouabain | 1 | 2002 | 24 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2022 | 38 | 0.050 |
Why?
|
Receptors, Muscarinic | 1 | 2002 | 49 | 0.050 |
Why?
|
Biomarkers, Tumor | 2 | 2011 | 1519 | 0.050 |
Why?
|
Bundle-Branch Block | 1 | 2002 | 54 | 0.050 |
Why?
|
Immunoglobulin E | 1 | 2022 | 145 | 0.050 |
Why?
|
Graft Rejection | 3 | 2018 | 1082 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 154 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 321 | 0.050 |
Why?
|
Interleukin-10 | 1 | 2022 | 151 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2016 | 558 | 0.050 |
Why?
|
Thiazoles | 1 | 2002 | 128 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 384 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 79 | 0.050 |
Why?
|
Biomarkers | 2 | 2019 | 1753 | 0.050 |
Why?
|
Receptors, Nicotinic | 1 | 2002 | 131 | 0.050 |
Why?
|
Reserpine | 1 | 2020 | 5 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2022 | 241 | 0.050 |
Why?
|
Benzamides | 1 | 2002 | 239 | 0.050 |
Why?
|
Fibrosis | 1 | 2022 | 237 | 0.050 |
Why?
|
Glucose | 1 | 2004 | 630 | 0.050 |
Why?
|
Perfusion | 1 | 2022 | 227 | 0.050 |
Why?
|
Trachea | 1 | 2002 | 291 | 0.050 |
Why?
|
Adolescent | 4 | 2009 | 9125 | 0.050 |
Why?
|
Carcinoma | 1 | 2004 | 441 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 1762 | 0.040 |
Why?
|
Gait | 1 | 2020 | 80 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2009 | 1710 | 0.040 |
Why?
|
Egtazic Acid | 1 | 2019 | 33 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2022 | 466 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 2528 | 0.040 |
Why?
|
Nociception | 1 | 2019 | 4 | 0.040 |
Why?
|
Exercise | 1 | 2002 | 321 | 0.040 |
Why?
|
Cardiac Catheters | 1 | 2019 | 12 | 0.040 |
Why?
|
DNA Damage | 1 | 2021 | 371 | 0.040 |
Why?
|
Neuralgia | 1 | 2019 | 30 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 645 | 0.040 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 51 | 0.040 |
Why?
|
Antiphospholipid Syndrome | 1 | 2018 | 20 | 0.040 |
Why?
|
Operative Time | 1 | 2019 | 136 | 0.040 |
Why?
|
Syndrome | 2 | 2013 | 448 | 0.040 |
Why?
|
Hypolipidemic Agents | 2 | 2009 | 99 | 0.040 |
Why?
|
Motor Activity | 1 | 2020 | 328 | 0.040 |
Why?
|
Kidney Glomerulus | 1 | 2018 | 121 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2018 | 506 | 0.040 |
Why?
|
Equipment Design | 1 | 2019 | 415 | 0.040 |
Why?
|
Allografts | 1 | 2018 | 176 | 0.040 |
Why?
|
Mesonephros | 1 | 2017 | 1 | 0.040 |
Why?
|
RNA Caps | 1 | 2017 | 8 | 0.040 |
Why?
|
Gonads | 1 | 2017 | 19 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 307 | 0.040 |
Why?
|
CLOCK Proteins | 1 | 2016 | 15 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2016 | 43 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2019 | 190 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2016 | 49 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 2016 | 47 | 0.040 |
Why?
|
Cell Separation | 1 | 2017 | 198 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2015 | 1846 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2017 | 223 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2020 | 1787 | 0.030 |
Why?
|
Retinoic Acid 4-Hydroxylase | 1 | 2016 | 10 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2012 | 1212 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 114 | 0.030 |
Why?
|
Electric Countershock | 1 | 2016 | 51 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2016 | 42 | 0.030 |
Why?
|
Vitamin A | 1 | 2016 | 28 | 0.030 |
Why?
|
Physical Stimulation | 2 | 2007 | 70 | 0.030 |
Why?
|
Models, Neurological | 1 | 2019 | 407 | 0.030 |
Why?
|
HeLa Cells | 1 | 2017 | 505 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 79 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 90 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 243 | 0.030 |
Why?
|
Aorta | 1 | 2017 | 286 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2006 | 471 | 0.030 |
Why?
|
Potassium | 1 | 2016 | 252 | 0.030 |
Why?
|
Cadmium | 1 | 2014 | 28 | 0.030 |
Why?
|
Body Weight | 1 | 2016 | 452 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 266 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 121 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2015 | 275 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 450 | 0.030 |
Why?
|
Apoptosis | 2 | 2016 | 1713 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2006 | 295 | 0.030 |
Why?
|
Binding Sites | 1 | 2016 | 1112 | 0.030 |
Why?
|
Excitation Contraction Coupling | 1 | 2013 | 8 | 0.030 |
Why?
|
Algorithms | 3 | 2009 | 1857 | 0.030 |
Why?
|
KATP Channels | 1 | 2013 | 19 | 0.030 |
Why?
|
Inflammation | 1 | 2019 | 957 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2013 | 57 | 0.030 |
Why?
|
Potassium Channel Blockers | 1 | 2013 | 64 | 0.030 |
Why?
|
Atrial Function | 1 | 2012 | 19 | 0.030 |
Why?
|
Protein Binding | 1 | 2016 | 1481 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2013 | 190 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 652 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2013 | 252 | 0.030 |
Why?
|
Gene Expression | 1 | 2016 | 1308 | 0.030 |
Why?
|
Disease Progression | 1 | 2016 | 1488 | 0.030 |
Why?
|
Granulocytes | 1 | 2011 | 38 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2012 | 122 | 0.030 |
Why?
|
Cell Line | 1 | 2016 | 2498 | 0.030 |
Why?
|
Adrenergic alpha-2 Receptor Antagonists | 1 | 2011 | 4 | 0.020 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2011 | 4 | 0.020 |
Why?
|
Iopamidol | 1 | 2011 | 10 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2011 | 241 | 0.020 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2011 | 14 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2019 | 2582 | 0.020 |
Why?
|
Animals, Outbred Strains | 1 | 2011 | 17 | 0.020 |
Why?
|
Iodine | 1 | 2011 | 43 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2011 | 156 | 0.020 |
Why?
|
Quality of Life | 1 | 2019 | 1646 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2015 | 1568 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2009 | 2001 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 684 | 0.020 |
Why?
|
Comorbidity | 1 | 2014 | 943 | 0.020 |
Why?
|
Hospitalization | 1 | 2016 | 868 | 0.020 |
Why?
|
Transcriptome | 1 | 2015 | 619 | 0.020 |
Why?
|
Intercostal Muscles | 1 | 2009 | 5 | 0.020 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2009 | 8 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 1057 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2016 | 1213 | 0.020 |
Why?
|
Chronic Disease | 1 | 2012 | 946 | 0.020 |
Why?
|
Biometry | 1 | 2009 | 66 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 430 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 1943 | 0.020 |
Why?
|
Homeostasis | 1 | 2011 | 407 | 0.020 |
Why?
|
Prevalence | 1 | 2012 | 1245 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2009 | 157 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 681 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2009 | 115 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2009 | 82 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 245 | 0.020 |
Why?
|
Aging | 1 | 2013 | 708 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2009 | 289 | 0.020 |
Why?
|
Patient Selection | 1 | 2011 | 686 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2009 | 263 | 0.020 |
Why?
|
Ions | 1 | 2007 | 74 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2006 | 119 | 0.020 |
Why?
|
Mycophenolic Acid | 1 | 2006 | 88 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2007 | 396 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2007 | 193 | 0.020 |
Why?
|
Pancreas Transplantation | 1 | 2006 | 104 | 0.020 |
Why?
|
Brain | 2 | 2007 | 2257 | 0.020 |
Why?
|
DNA Probes | 1 | 2006 | 77 | 0.020 |
Why?
|
Azathioprine | 1 | 2006 | 125 | 0.020 |
Why?
|
Contrast Media | 1 | 2011 | 1084 | 0.020 |
Why?
|
Drug Combinations | 1 | 2006 | 202 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2006 | 294 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2006 | 73 | 0.020 |
Why?
|
Asthma | 1 | 2013 | 972 | 0.020 |
Why?
|
Drug Synergism | 1 | 2006 | 305 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2006 | 130 | 0.020 |
Why?
|
Models, Chemical | 1 | 2006 | 179 | 0.020 |
Why?
|
Tacrolimus | 1 | 2006 | 374 | 0.020 |
Why?
|
Databases, Factual | 1 | 2009 | 846 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2009 | 441 | 0.020 |
Why?
|
Genetic Markers | 1 | 2006 | 477 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 332 | 0.020 |
Why?
|
Nociceptors | 1 | 2004 | 29 | 0.020 |
Why?
|
Cesium | 1 | 2003 | 25 | 0.010 |
Why?
|
Reoperation | 1 | 2006 | 606 | 0.010 |
Why?
|
Huntington Disease | 1 | 2004 | 37 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2003 | 31 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2004 | 51 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2004 | 134 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 221 | 0.010 |
Why?
|
Thionucleotides | 1 | 2003 | 56 | 0.010 |
Why?
|
Stochastic Processes | 1 | 2004 | 77 | 0.010 |
Why?
|
Genes, myc | 1 | 2003 | 39 | 0.010 |
Why?
|
Serologic Tests | 1 | 2003 | 44 | 0.010 |
Why?
|
Radiosurgery | 1 | 2006 | 280 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 192 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2003 | 49 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 2003 | 172 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 562 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2003 | 105 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 575 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 1186 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 391 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2003 | 159 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 565 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2002 | 167 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 743 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 431 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 1226 | 0.010 |
Why?
|
Gastrointestinal Agents | 1 | 2002 | 166 | 0.010 |
Why?
|
Pregnancy | 1 | 2006 | 2986 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2008 | 1163 | 0.010 |
Why?
|